Jens-Ulrich Rahfeld

This inventor holds 19 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 12 EPO patents, primarily in Antibody Development. Top assignees: Probiodrug Ag, Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v., Vivoryon Therapeutics N.v.. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jens-Ulrich Rahfeld. Retrieved from https://idiyas.com/inventor/jens-ulrich-rahfeld

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 9)

% Patents Active = 68.4

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 12 (Patent Applications = 19)

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 47(Granted Patents)

Location History:

Roblingen Am See, DE (2013)
Röblingen Am See, DE (2014)
Mansfelder Land, DE (2014)
OT Roeblingen am See, DE (2014)
Lieskau, DE (2010 - 2017)
Seegebiet Mansfelder Land, DE (2021 - 2023)
Gemeinde Seegebiet Mansfelder Land, DE (2014 - 2024)

Company Filing History:

Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.

patents

1 out of 5

Vivoryon Therapeutics N.v.

patents

Years Active: 2010-2024

Loading Chart...

Areas of Expertise:

Humanized Antibodies

Amyloid-Beta

Diagnostic Assay

Glutaminyl Cyclase

Enzyme Inhibitors

Periodontitis Treatment

Inflammatory Diseases

Neurological Disorders

MCP-1

Pyroglutamate

Antibody Uses

Crystal Structure

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12043659 - Humanized and de-immunized antibodies (2024-07-23),

2. 11703511 - Anti-isoAsp7 amyloid β (Aβ) antibodies and uses thereof (2023-07-18),

3. 11186572 - Bacterial glutaminyl cyclases and inhibitors thereof for use in the treatment of periodontitis (2021-11-30),

4. 11045533 - Humanized antibodies (2021-06-29),

5. 10603367 - Humanized antibodies (2020-03-31),

6. 9676843 - Uses of antibodies directed against amyloid-β (2017-06-13),

7. 9657089 - Diagnostic antibody assay (2017-05-23),

8. 9157918 - Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE) (2015-10-13),

9. 9156907 - Diagnostic antibody assay (2015-10-13),

10. 8889709 - Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions (2014-11-18),

11. 8859250 - Crystal structure of glutaminyl cyclase (2014-10-14),

12. 8809508 - Diagnostic antibody assay (2014-08-19),

13. 8741614 - Crystal structure of isoglutaminyl cyclase (2014-06-03),

14. 8647834 - Screening method for enzyme inhibitors (2014-02-11),

15. 8518406 - Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE) (2013-08-27),

Title: The Innovative Mind of Jens-Ulrich Rahfeld

Introduction:

Jens-Ulrich Rahfeld, a talented inventor hailing from Lieskau, Germany, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Rahfeld's latest patents showcase his expertise in developing cutting-edge solutions for various industries, including renewable energy, telecommunications, and healthcare.

Career Highlights:

With a career spanning over two decades, Rahfeld has consistently pushed the boundaries of innovation, holding numerous patents that have revolutionized the way we approach complex challenges in the modern world.

Collaborations:

Throughout his career, Rahfeld has collaborated with leading research institutions, universities, and multinational companies to bring his visionary ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion:

In conclusion, Jens-Ulrich Rahfeld's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the global technology landscape. His work continues to inspire future generations of inventors to think boldly and push the limits of what is possible.

Profile summary based on public USPTO records.